Literature DB >> 10835682

Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors.

K Oritani1, K L Medina, Y Tomiyama, J Ishikawa, Y Okajima, M Ogawa, T Yokota, K Aoyama, I Takahashi, P W Kincade, Y Matsuzawa.   

Abstract

We have identified an interferon-like cytokine, limitin, on the basis of its ability to arrest the growth of or kill lympho-hematopoietic cells. Limitin strongly inhibited B lymphopoiesis in vitro and in vivo but had little influence on either myelopoiesis or erythropoiesis. Because limitin uses the interferon alpha/beta receptors and induces interferon regulatory factor-1, it may represent a previously unknown type I interferon prototype. However, preferential B-lineage growth inhibition and activation of Janus kinase 2 in a myelomonocytic leukemia line have not been described for previously known interferons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10835682     DOI: 10.1038/76233

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  25 in total

Review 1.  What is Good's syndrome? Immunological abnormalities in patients with thymoma.

Authors:  P Kelleher; S A Misbah
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

2.  Good's syndrome, CVID, and selective antibody deficiency in patients with chronic rhinosinusitis.

Authors:  Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

Review 3.  Interferon-zeta/limitin: novel type I interferon that displays a narrow range of biological activity.

Authors:  Kenji Oritani; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

4.  mRNAs and miRNAs in whole blood associated with lung hyperplasia, fibrosis, and bronchiolo-alveolar adenoma and adenocarcinoma after multi-walled carbon nanotube inhalation exposure in mice.

Authors:  Brandi N Snyder-Talkington; Chunlin Dong; Linda M Sargent; Dale W Porter; Lauren M Staska; Ann F Hubbs; Rebecca Raese; Walter McKinney; Bean T Chen; Lori Battelli; David T Lowry; Steven H Reynolds; Vincent Castranova; Yong Qian; Nancy L Guo
Journal:  J Appl Toxicol       Date:  2015-04-29       Impact factor: 3.446

5.  The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages.

Authors:  Yusuke Satoh; Takafumi Yokota; Takao Sudo; Motonari Kondo; Anne Lai; Paul W Kincade; Taku Kouro; Ryuji Iida; Koichi Kokame; Toshiyuki Miyata; Yoko Habuchi; Keiko Matsui; Hirokazu Tanaka; Itaru Matsumura; Kenji Oritani; Terumi Kohwi-Shigematsu; Yuzuru Kanakura
Journal:  Immunity       Date:  2013-06-20       Impact factor: 31.745

6.  Characterization of the murine alpha interferon gene family.

Authors:  Vincent van Pesch; Hanane Lanaya; Jean-Christophe Renauld; Thomas Michiels
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.

Authors:  Shin-Ichiro Kawamoto; Kenji Oritani; Hideo Asada; Isao Takahashi; Jun Ishikawa; Hitoshi Yoshida; Masahide Yamada; Naoko Ishida; Hidetoshi Ujiie; Hiroaki Masaie; Yoshiaki Tomiyama; Yuji Matsuzawa
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 8.  Beyond autophagy: New roles for ULK1 in immune signaling and interferon responses.

Authors:  Diana Saleiro; Ewa M Kosciuczuk; Leonidas C Platanias
Journal:  Cytokine Growth Factor Rev       Date:  2016-04-01       Impact factor: 7.638

9.  Molecular and functional characterization of canine interferon-epsilon.

Authors:  Limin Yang; Lei Xu; Yun Li; Jing Li; Yuhai Bi; Wenjun Liu
Journal:  J Interferon Cytokine Res       Date:  2013-08-21       Impact factor: 2.607

10.  Characterization of the bovine type I IFN locus: rearrangements, expansions, and novel subfamilies.

Authors:  Angela M Walker; R Michael Roberts
Journal:  BMC Genomics       Date:  2009-04-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.